In this segment, Ashley shares how she was able to land on a newly FDAapproved targeted treatment (osimertinib or Tagrisso) that allowed her to skip chemotherapy through an IV at the hospital and instead, take a daily pill. She shares how she was able to get such a new drug approved through her insurance, her followup schedule with her oncologist, and delves also into the side effects and how she’s been able to get through them as best as she can every day.
Navigation → see below for time codes to different subsections.

In this Series: Our 3part series with Ashley covers her from how she got diagnosed, to the targeted therapy that had just been approved for her cancer subtype and genetic mutation (EGFR+ T790M) that allowed her to take a pill (osimertinib or Tagrisso) instead of traditional chemotherapy, through how she lives with her incurable but treatable disease.

Full story & transcript →https://www.thepatientstory.com/patie...

The interview has only been edited for clarity.

Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
______________________________

Contents of this video:
0:00 Intro: Treatment & Testing
0:57 Describe the scan of your lungs
1:59 Deciding where to get treatment
4:48 The Genomic Testing
11:42 Targeted Therapy (osimertinib) Schedule
13:07 Dealing with side effects
21:45 Giving yourself Grace
25:28 Experience of brand new treatment
31:49 Monitoring schedule with oncologist

______________________________

#LungCancer #Cancer #ThePatientStory
#egfr #genomictesting #clinicaltrials #targetedtherapy #osimertinib #tagrisso #astrazeneca